fda removes semaglutide from drug shortage list february 2025 Ozempic and Wegovy removed the FDA's Ozempic and Wegovy are no
Description
Personalized weight management with GLP1 therapies in Henderson and Las Vegas, NV to reduce appetite, support metabolism, & achieve lasting wellness

As a result, many members turned to diabetes-indicated GLP-1s off-label, creating shortages that impacted patients who needed them for type 2 diabetes

Results may be more applicable to real-world practice

The situation is causing the FDA regulatory headaches and, more seriously, posing potential risks to the public.

An abstract presented at the ADA 85th Scientific Sessions showed that obesity telemedicine plus GLP-1 therapy yielded improvements in multiple outcomes.

Talk to our AI doctor today.